Literature DB >> 15639801

Metallothionein biology in the ageing and neurodegenerative brain.

J Dittmann1, S J Fung, J C Vickers, M I Chuah, R S Chung, A K West.   

Abstract

In recent years metallothionein (MT) biology has moved from investigation of its ability to protect against environmental heavy metals to a wider appreciation of its role in responding to cellular stress, whether as a consequence of normal function, or following injury and disease. This is exemplified by recent investigation of MT in the mammalian brain where plausible roles for MT action have been described, including zinc metabolism, free radical scavenging, and protection and regeneration following neurological injury. Along with other laboratories we have used several models of central nervous system (CNS) injury to investigate possible parallels between injury-dependent changes in MT expression and those observed in the ageing and/or degenerating brain. Therefore, this brief review aims to summarise existing information on MT expression during CNS ageing, and to examine the possible involvement of this protein in the course of human neurodegenerative disease, as exemplified by Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15639801     DOI: 10.1007/BF03033779

Source DB:  PubMed          Journal:  Neurotox Res        ISSN: 1029-8428            Impact factor:   3.911


  55 in total

1.  Metallothionein (MT)-III: generation of polyclonal antibodies, comparison with MT-I+II in the freeze lesioned rat brain and in a bioassay with astrocytes, and analysis of Alzheimer's disease brains.

Authors:  J Carrasco; M Giralt; A Molinero; M Penkowa; T Moos; J Hidalgo
Journal:  J Neurotrauma       Date:  1999-11       Impact factor: 5.269

2.  Human brain S100 beta and S100 beta mRNA expression increases with age: pathogenic implications for Alzheimer's disease.

Authors:  J G Sheng; R E Mrak; C R Rovnaghi; E Kozlowska; L J Van Eldik; W S Griffin
Journal:  Neurobiol Aging       Date:  1996 May-Jun       Impact factor: 4.673

3.  Changes in brain gene expression shared by scrapie and Alzheimer disease.

Authors:  J R Duguid; C W Bohmont; N G Liu; W W Tourtellotte
Journal:  Proc Natl Acad Sci U S A       Date:  1989-09       Impact factor: 11.205

Review 4.  Roles of the metallothionein family of proteins in the central nervous system.

Authors:  J Hidalgo; M Aschner; P Zatta; M Vasák
Journal:  Brain Res Bull       Date:  2001-05-15       Impact factor: 4.077

5.  Expression of growth inhibitory factor (metallothionein-III) mRNA and protein following excitotoxic immature brain injury.

Authors:  L Acarin; J Carrasco; B González; J Hidalgo; B Castellano
Journal:  J Neuropathol Exp Neurol       Date:  1999-04       Impact factor: 3.685

6.  Sheep have an unusual variant of the brain-specific metallothionein, metallothionein-III.

Authors:  Roger S Chung; Adele F Holloway; Bedrich L Eckhardt; Julie A Harris; James C Vickers; Meng Inn Chuah; Adrian K West
Journal:  Biochem J       Date:  2002-07-01       Impact factor: 3.857

7.  Speciation analysis of trace elements in the brains of individuals with Alzheimer's disease with special emphasis on metallothioneins.

Authors:  Andrea-Nicole Richarz; Peter Brätter
Journal:  Anal Bioanal Chem       Date:  2002-01-09       Impact factor: 4.142

8.  Role of metallothionein-III following central nervous system damage.

Authors:  Javier Carrasco; Milena Penkowa; Mercedes Giralt; Jordi Camats; Amalia Molinero; Iain L Campbell; Richard D Palmiter; Juan Hidalgo
Journal:  Neurobiol Dis       Date:  2003-06       Impact factor: 5.996

9.  Metallothionein-I overexpression decreases brain pathology in transgenic mice with astrocyte-targeted expression of interleukin-6.

Authors:  Amalia Molinero; Milena Penkowa; Joaquín Hernández; Jordi Camats; Mercedes Giralt; Natalia Lago; Javier Carrasco; Iain L Campbell; Juan Hidalgo
Journal:  J Neuropathol Exp Neurol       Date:  2003-03       Impact factor: 3.685

10.  Distribution of metallothionein in the human central nervous system.

Authors:  H G Blaauwgeers; P A Sillevis Smitt; J M De Jong; D Troost
Journal:  Glia       Date:  1993-05       Impact factor: 7.452

View more
  7 in total

Review 1.  Biochemical, cellular and behavioural aspects of neurodegeneration: the view from down under.

Authors:  David H Small
Journal:  Neurotox Res       Date:  2005       Impact factor: 3.911

2.  Transcriptome signature of virulent and attenuated pseudorabies virus-infected rodent brain.

Authors:  Christina Paulus; Patricia J Sollars; Gary E Pickard; Lynn W Enquist
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

Review 3.  Metallothionein in the central nervous system: Roles in protection, regeneration and cognition.

Authors:  Adrian K West; Juan Hidalgo; Donnie Eddins; Edward D Levin; Michael Aschner
Journal:  Neurotoxicology       Date:  2008-01-19       Impact factor: 4.294

Review 4.  Neurotoxins and neurotoxicity mechanisms. An overview.

Authors:  Juan Segura-Aguilar; Richard M Kostrzewa
Journal:  Neurotox Res       Date:  2006-12       Impact factor: 3.911

Review 5.  Neuroprotection and regeneration by extracellular metallothionein via lipoprotein-receptor-related proteins.

Authors:  Adrian K West; Jacqueline Y K Leung; Roger S Chung
Journal:  J Biol Inorg Chem       Date:  2011-07-21       Impact factor: 3.358

6.  Gene expression in the rat brain during prostaglandin D2 and adenosinergically-induced sleep.

Authors:  Akira Terao; Zhi-Li Huang; Jonathan P Wisor; Takatoshi Mochizuki; Dmitry Gerashchenko; Yoshihiro Urade; T S Kilduff
Journal:  J Neurochem       Date:  2008-03-07       Impact factor: 5.372

7.  Putative psychosis genes in the prefrontal cortex: combined analysis of gene expression microarrays.

Authors:  Kwang Ho Choi; Michael Elashoff; Brandon W Higgs; Jonathan Song; Sanghyeon Kim; Sarven Sabunciyan; Suad Diglisic; Robert H Yolken; Michael B Knable; E Fuller Torrey; Maree J Webster
Journal:  BMC Psychiatry       Date:  2008-11-07       Impact factor: 3.630

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.